ライフサイエンスコーパス: tissue engineering

1 s, including 3D cell culture and micro-scale tissue engineering.

2 tem for the application of 3D bioprinting in tissue engineering.

3 ing, cell-cell fusion and communication, and tissue engineering.

4 otics, biomedical devices, drug delivery and tissue engineering.

5 ive diagnostic capabilities, biosensing, and tissue engineering.

6 d the delivery of therapeutics and cells for tissue engineering.

7 aining and simulations to mechanobiology and tissue engineering.

8 describing Lab-on-a-chip systems for cardiac tissue engineering.

9 manufactured scaffold design for functional tissue engineering.

10 ate cell-laden membranes for cell culture or tissue engineering.

11 onsidered as an appealing candidate for bone tissue engineering.

12 cell culture applications, cell therapy and tissue engineering.

13 for contrast enhanced ultrasound imaging, in tissue engineering.

14 stomizable production of cellular layers for tissue engineering.

15 ntrol release systems that are used for bone tissue engineering.

16 racted significant attention in the field of tissue engineering.

17 g cell-free scaffold-based miRNA therapy for tissue engineering.

18 ze this information for future strategies in tissue engineering.

19 els for cancer and drug research, as well as tissue engineering.

20 n, shapes the current concept of periodontal tissue engineering.

21 be exploited to form adaptable hydrogels for tissue engineering.

22 nes and contributing towards developments in tissue engineering.

23 roids, and microgels and achieving bottom-up tissue engineering.

24 om soft biomedical devices to constructs for tissue engineering.

25 ner hydrogel scaffolds viable for biomimetic tissue engineering.

26 ioimpedance tracking of 3D cell cultures and tissue engineering.

27 ave been integral for advancing the field of tissue engineering.

28 bioactive scaffolds for applications such as tissue engineering.

29 cular research and for regenerative medicine/tissue engineering.

30 rs for the purposes of controlled release in tissue engineering.

31 offering customized cell-based therapies for tissue engineering.

32 differentiation, cell-surface tailoring, and tissue engineering.

33 pplications, especially in drug delivery and tissue engineering.

34 ensing, molecular imaging, drug delivery and tissue engineering.

35 uses as a bioactive peptide by itself or in tissue engineering.

36 lications in diagnostics, drug delivery, and tissue engineering.

37 l reagents to guide and regulate heart valve tissue engineering.

38 H)D3 has great potential for cell-based bone tissue engineering.

39 on by enabling the long-term goal of in situ tissue engineering.

40 ccine/gene delivery and its applicability in tissue engineering.

41 ease, or as patterned scaffolds for directed tissue engineering.

42 tro would represent an important advance for tissue engineering.

43 caffolds or supporting substrates for neural tissue engineering.

44 small volumes targeting applications such as tissue engineering.

45 se facets of the challenging field of neural tissue engineering.

46 or controlled three-dimensional culture, and tissue engineering.

47 e major questions relevant to cardiovascular tissue engineering.

48 mmalian cells, with applications in cell and tissue engineering.

49 bal niche as culture matrices for epithelial tissue engineering.

50 ted NDs to develop a novel platform for bone tissue engineering.

51 long-standing challenge for stem cell-based tissue engineering.

52 properties very suitable to apply in corneal tissue engineering.

53 nging from advanced drug delivery systems to tissue engineering.

54 s (10%) scaffolds for drug delivery and bone tissue engineering.

55 tion as a key design parameter for cartilage tissue engineering.

56 e fabrication of nanocomposite hydrogels for tissue engineering.

57 on is essential for the advancement of liver tissue engineering.

58 a step towards a humanized in vivo model for tissue engineering.

59 ined drug delivery, noninvasive imaging, and tissue engineering.

60 Tissue engineering, a recent promising way to possibly r

61 gineering, particularly biosensing, cell and tissue engineering, actuators, and drug delivery.

62 ancers and as modulators of Wnt signaling in tissue-engineering agendas, their impact on telomere len

63 ily low concentrations, with applications in tissue engineering, agriculture, water purification and

64 Tissue engineering aims to utilise biologic mediators to

65 ollagen-based hydrogels are commonly used in tissue engineering and as matrices for biophysical studi

66 combination of techniques from 3D printing, tissue engineering and biomaterials has yielded a new cl

67 ghly relevant to bionic interface design for tissue engineering and bionic devices.

68 new avenue in biomaterial design to advance tissue engineering and cell delivery.

69 , as well as providing a source of cells for tissue engineering and cell therapy approaches.

70 em cells (hPSCs) offer tremendous promise in tissue engineering and cell-based therapies due to their

71 d have far-reaching application in a host of tissue engineering and cell-based therapies.

72 optoelectronics, microfabrication, sensors, tissue engineering and computation.

73 Here, we review the state of the art in tissue engineering and describe how tissue engineering t

74 terials is desirable for point-of-care (POC) tissue engineering and diagnostics.

75 research topic; because their application in tissue engineering and disease modeling have great poten

76 therapy, and it could be extended to muscle tissue engineering and disease modeling.

77 dothelium remains a fundamental challenge in tissue engineering and drug development.

78 ese miniaturized systems very attractive for tissue engineering and drug screening applications.

79 modulus and mass density; then in bottom-up tissue engineering and finally, levitational and selecti

80 angiogenic approach for applications such as tissue engineering and ischemic tissue disorders.

81 s in human stem cell biology and technology, tissue engineering and material sciences, as well as pre

82 Controlling cell migration is important in tissue engineering and medicine.

83 th biologists to leverage recent advances in tissue engineering and microfabrication to develop novel

84 Advances in tissue engineering and microtechnology have enabled rese

85 generating large numbers of human EpSCs for tissue engineering and new treatments for hair loss, wou

86 enges that must be addressed in the field of tissue engineering and provide a perspective regarding s

87 l interactions are of critical importance in tissue engineering and regeneration strategies that seek

88 ng pathogenesis and to devise strategies for tissue engineering and regeneration.

89 Tissue engineering and regenerative medicine aim to rege

90 le hydrogels should find use in a variety of tissue engineering and regenerative medicine application

91 acrophage balance and properly exploit it in tissue engineering and regenerative medicine application

92 enesis holds great potential for a myriad of tissue engineering and regenerative medicine approaches.

93 onal porous scaffolds play a pivotal role in tissue engineering and regenerative medicine by function

94 technologies and biomaterials developed for tissue engineering and regenerative medicine present tra

95 ent to promote maintenance of stem cells for tissue engineering and regenerative medicine purposes.

96 invasive procedures and are often applied in tissue engineering and regenerative medicine strategies.

97 We then showcase their broad applications in tissue engineering and regenerative medicine, followed b

98 ms as a novel class of nano-fibrous mats for tissue engineering and regenerative medicine.

99 tissue and are widely used biomaterials for tissue engineering and regenerative medicine.

100 a mat will have wide utility in the areas of tissue engineering and regenerative medicine.

101 fundamental concepts associated with muscle-tissue engineering and the current status of muscle-tiss

102 posed as a means to improve cell culture and tissue engineering and to treat disease.

103 findings have implications for angiogenesis, tissue engineering and vascular disease.

104 f gene delivery, drug delivery, bio-imaging, tissue engineering, and antimicrobials.

105 e use of NDs in the fields of drug delivery, tissue engineering, and bioimaging.

106 the increasing demand of stem cell research, tissue engineering, and drug screening.

107 s in genome editing, cellular reprogramming, tissue engineering, and information technologies, especi

108 and delivery of materials in pharmaceutics, tissue engineering, and photonics.

109 erapeutic strategies including cell therapy, tissue engineering, and regenerative medicine and are fr

110 oad applications in cell biology, pathology, tissue engineering, and related biomedical studies.

111 iverse as electronics, structural materials, tissue engineering, and soft robotics.

112 ations, including living cell encapsulation, tissue engineering, and stimuli responsive controlled de

113 d system (CM-ALs) for drug delivery and bone tissue engineering application.

114 nd application of nanocomposite hydrogels in tissue engineering applications are described, with spec

115 , has established a good reputation for bone tissue engineering applications due to its many unique p

116 Biomaterial development for tissue engineering applications is rapidly increasing bu

117 to mimicking native tissue architecture for tissue engineering applications is to engineer fibrous s

118 In tissue engineering applications the fluorescent fibre ne

119 ical devices, such as biosensors, as well as tissue engineering applications where both a vascularize

120 stem cells, which are commonly used in many tissue engineering applications, indicates that they may

121 For bone tissue engineering applications, tissue collection typic

122 ce acellular urethra bioscaffolds for future tissue engineering applications, using bioscaffolds or b

123 ancer and stem cell research, as well as for tissue engineering applications.

124 drug delivery, gene therapy, biosensors, and tissue engineering applications.

125 n the M1 and M2 phenotypes in the context of tissue engineering applications.

126 stem cell phenotype suitable for downstream tissue engineering applications.

127 degradation profiles of PU scaffolds used in tissue engineering applications.

128 readily tailored to different biomedical and tissue engineering applications.

129 s an exciting property for their use in bone tissue engineering applications.

130 es are being exploited for drug delivery and tissue engineering applications.

131 and multiplexed manner for a broad range of tissue engineering applications.

132 raphene/nano-58S composite scaffold for bone tissue engineering applications.

133 e repair and holds promise for osteochondral tissue engineering applications.

134 models, treatments of myopathies, and other tissue engineering applications.

135 ve polymers attractive for drug delivery and tissue engineering applications.

136 ew biomaterial formulations for craniofacial tissue engineering applications.

137 vel bioink and a dispensing technique for 3D tissue-engineering applications are presented.

138 architectures, demonstrating feasibility for tissue-engineering applications.

139 biophysical and biochemical signals, and for tissue-engineering applications.

140 que opportunities for controlled-release and tissue-engineering applications.

141 lled manner has the potential to augment the tissue engineering approach.

142 ent bioactions that offers a new therapeutic tissue-engineering approach for the treatment of chronic

143 We used a tissue-engineering approach with embryonic and induced p

144 nd delivery systems, and also cell-based and tissue engineering approaches for SCI.

145 Tissue engineering approaches have the potential to incr

146 Most tissue engineering approaches have tried to improve the

147 The use of tissue engineering approaches in combination with exogen

148 Therefore, tissue engineering approaches that incorporate immature

149 engineering and the current status of muscle-tissue-engineering approaches is provided.

150 gies in neural, skin, connective, and muscle tissue engineering are explored.

151 Current approaches in tissue engineering are geared toward generating tissue-s

152 of anisotropic materials in skeletal-muscle-tissue engineering are highlighted, along with their pot

153 lled and targeted delivery of bioactives and tissue engineering are the current research interests of

154 fields, such as 3D bioprinting and bottom-up tissue engineering, as well as drug discovery, developme

155 cations of BOEC: their use for gene therapy, tissue engineering, assessment of mutant gene effect, an

156 In tissue engineering, autofluorescence of polymer scaffold

157 o and in vivo pre-clinical and human models, tissue-engineering-based strategies continue to demonstr

158 drug screening is particularly important in tissue engineering because of the high frequency of drug

159 system an excellent theranostic platform for tissue engineering, biomapping, and cellular imaging app

160 An emerging challenge in tissue engineering biomimetic models is recapitulating t

161 variety of biomedical applications including tissue engineering, biomolecule delivery, cell delivery,

162 ports for cells in regenerative medicine and tissue engineering, biosensing and construction of micro

163 delivery of the building blocks for in situ tissue engineering, but will also be essential to unders

164 also use coded microstructures for bottom-up tissue engineering by generating cell-encapsulating cons

165 ere we present a notable advance in vascular tissue engineering by generating the first functional 3-

166 peutic strategies based on the principles of tissue engineering by self-assembly put forward the noti

167 We also demonstrate POC tissue engineering by writing a continuous pattern of li

168 nipulation for applications in areas such as tissue engineering can require mesoscale structures to b

169 Tissue-engineering can serve as an alternative to conven

170 t of such organotypic cultures has impact in tissue engineering, cancer therapy and personalized medi

171 fied by their applications in cell cultures, tissue engineering, cell behavior, imaging, and unique a

172 range of biomedical applications such as in tissue engineering, cell encapsulation, microfluidics, b

173 In cardiac tissue engineering cells are seeded within porous biomat

174 ay therefore substantially simplify previous tissue engineering concepts toward clinical translation.

175 lammatory process can promote the success of tissue engineering constructs.

176 of biomineralization for intact real-size 3D tissue engineering constructs.

177 , cells, and soluble mediators necessary for tissue engineering, control of endogenous inflammation i

178 s have been achieved in the field of cardiac tissue engineering, current in vitro cardiac tissues do

179 damental challenge to apply the materials in tissue engineering, diagnostics, proteomics and biosenso

180 tial utility in drug delivery, nanoreactors, tissue engineering, diagnostics, rheology modifiers, enz

181 ney organoids to facilitate applications for tissue engineering, disease modeling and chemical screen

182 form for regenerative medicine, development, tissue engineering, disease modeling, and drug toxicity

183 rs (TFs) is a powerful and exciting tool for tissue engineering, disease modeling, and regenerative m

184 applications in cementitious materials, bone-tissue engineering, drug delivery and refractory materia

185 applications in drug screening, programmable tissue engineering, drug delivery, and biomimetic machin

186 The application of bioprinting technology in tissue engineering enables the development of a 3D biomi

187 Tissue engineering enables the generation of functional

188 appropriate biomaterials impacts success in tissue engineering endeavors.

189 The field of tissue engineering entered a new era with the developmen

190 Many applications in tissue engineering, flexible electronics, and soft robot

191 intrinsic complexity of the goal of nanotech tissue engineering for a conscious approach to the devel

192 rt, bottlenecks, and perspectives of cardiac tissue engineering for cardiac repair and in vitro testi

193 toward the real-life application of cardiac tissue engineering for disease modeling, drug developmen

194 ng approach for xeno-free corneal epithelial tissue engineering for ocular surface reconstruction.

195 will promote the translation of craniofacial tissue engineering from the laboratory bench to the chai

196 Tissue engineering, gene therapy, drug screening, and em

197 lication of rapid, digital 3D bioprinting to tissue engineering has allowed 3D patterning of multiple

198 ntly available valve prosthesis, heart valve tissue engineering has emerged as a promising technique

199 So far, the field of tissue engineering has not full-filled its grand potenti

200 Cell-based tissue engineering has recently been introduced, and res

201 ions in nanotechnology for drug delivery and tissue engineering have delivered high-impact contributi

202 Advances in the field of tissue engineering have enhanced the potential of regene

203 Recent advances in the field of GI tissue engineering have focused on the use of scaffoldin

204 Advances in tissue engineering have led to innovative scaffold desig

205 l function make tendon a prime candidate for tissue engineering; however functional tendons have yet

206 iomyocytes provide a cell source for cardiac tissue engineering; however, their immaturity limits the

207 so have potential as a translational tool in tissue engineering; however, this potential is limited b

208 Tissue engineering in endoscopy is also being pioneered

209 ing new therapeutic strategy for dentin/pulp tissue engineering in future endodontic treatment.

210 omising therapeutic strategy for dentin/pulp tissue engineering in future endodontic treatment.

211 ease, cancer therapy, DNA/siRNA delivery and tissue engineering in new aspects are discussed.

212 s progress has been achieved in the field of tissue engineering in the past decade.

213 lls (ECs) for therapeutic vascularization or tissue engineering is a promising method for increasing

214 em cells are remarkable, and stem cell-based tissue engineering is an emerging field of biomedical sc

215 Currently, the field of tissue engineering is focused on delivering complex matr

216 Tissue engineering is often referred to as a three-prong

217 Tissue engineering is one of the most prominent examples

218 A challenge for tissue engineering is producing three-dimensional (3D),

219 move forward in the field, a new pathway in tissue engineering is proposed.

220 A major challenge in tissue engineering is the development of materials that

221 A classical paradigm of tissue engineering is to grow tissues for implantation b

222 The goal of tissue engineering is to mitigate the critical shortage

223 The primary aim in tissue engineering is to repair, replace, and regenerate

224 ay the foundation for future improvements in tissue engineering, joint surgery, and cartilage-specifi

225 larization for the clinical applicability of tissue engineering, many approaches have been investigat

226 s include long-term culturing, 3-dimensional tissue engineering, mechanical loading, electric stimula

227 ent state-of-the-art biomedical implants and tissue engineering methods promise technologies to impro

228 combinatorial and native-like scaffolds for tissue engineering of functional organs.

229 atrix distribution present challenges in the tissue engineering of functional TMJ discs.

230 nt when, for example, designing scaffolds in tissue engineering or developing cures for diseases asso

231 ospinning of nanoparticles or nanofibers for tissue engineering or drug delivery/pharmaceutical purpo

232 ar and mechanical regulators on development, tissue engineering, or tumor progression.

233 e, this method can also be incorporated into tissue engineering platforms in which depletion of the s

234 advances in controlled release of drugs from tissue engineering platforms.

235 ases are limited by the inability of current tissue-engineering procedures to restore lost hard and s

236 A typical tissue-engineering process involves the design and fabri

237 the generation of urethra bioscaffold-based Tissue Engineering products.

238 This article is a review of the tissue engineering programs of the National Heart, Lung,

239 As the field of tissue engineering progresses ever-further toward realiz

240 isolation and propagation of human EpSCs for tissue engineering purposes remains a challenge.

241 well as their applications in drug delivery, tissue engineering, regenerative medicine and immunology

242 a range of biomedical applications including tissue engineering, regenerative medicine, and cell and

243 A goal for periodontal tissue engineering/regenerative medicine is to restore o

244 Tissue engineering/regenerative medicine provide new ave

245 ations as advanced materials in biomedicine, tissue engineering, renewable energy, environmental scie

246 As an alternative, tissue engineering represents a promising approach for t

247 ss this problem, we demonstrate that modular tissue engineering results in an s.c. vascularized bed t

248 ed release of their contents in the guise of tissue engineering scaffolds or medical devices for drug

249 ploited together with growth factors as bone tissue engineering scaffolds regulating cell behavior.

250 s significant interest in the development of tissue engineering scaffolds that can serve as biocompat

251 Development of tissue engineering scaffolds with native-like biology an

252 ased applications as wound-healing matrices, tissue engineering scaffolds, and even substrates for st

253 gradable elastomers are a popular choice for tissue engineering scaffolds, particularly in mechanical

254 s formed, making them materials of choice as tissue engineering scaffolds.

255 e as diagnostic reagents, drug carriers, and tissue engineering scaffolds.

256 Cs and hence, would be beneficial for neural tissue engineering scaffolds.

257 for nondestructive characterization of bone tissue engineering scaffolds.

258 the field of advanced paper or as bioactive tissue engineering scaffolds.

259 roperties is a promising platform for future tissue-engineering scaffolds and biomedical applications

260 h as drug delivery, macroscopic injectables, tissue-engineering scaffolds, and nano-imaging agents.

261 lds such as templated nanomaterial assembly, tissue-engineering scaffolds, or therapeutic delivery sy

262 In tissue engineering scenarios, after implantation of any

263 em cell research, regenerative medicine, and tissue engineering seems a promising approach to produce

264 d bio-integrated electronics, microfluidics, tissue engineering, soft robotics and biomedical devices

265 d for applications such as medical implants, tissue engineering, soft robotics, and wearable electron

266 , which has relevance for the design of bone tissue engineering strategies and may inform clinical tr

267 Genetic and tissue engineering strategies were applied to improve re

268 ystem plays a crucial role in the success of tissue engineering strategies.

269 on phenotypes with potential applications in tissue engineering strategies.

270 OA, have the potential to be repaired using tissue engineering strategies; however, it remains chall

271 rather than the cells themselves, and use of tissue-engineering strategies to provide structural supp

272 y demonstrates the feasibility of applying a tissue engineering strategy towards the development of s

273 Significantly, a five-week tissue engineering study demonstrated that printed oMSCs

274 ks might be interfaced with tissues, used as tissue engineering substrates, or developed as mimics of

275 Most tissue engineering systems draw conclusions on tissue fu

276 tentially applicable as scaffolds in cardiac tissue engineering (TE).

277 the latter system, we have reported a novel tissue engineering technique by implementing 5 weekly kn

278 e art in tissue engineering and describe how tissue engineering techniques may alleviate some common

279 Tissue engineering techniques may enable virologists to

280 a realistic option and predict that cardiac tissue engineering techniques will find widespread use i

281 Recently, tissue engineering technology has been developed and app

282 Accordingly, therapies based on tissue engineering that leverage local self-healing pote

283 we highlight recent advances in the field of tissue engineering that suggest novel strategies to enha

284 ontrol is highly significant for bioscaffold tissue engineering, the evolution of bone microarchitect

285 bariatric interventions, drug delivery, and tissue engineering.The use of drug delivery systems for

286 liorate the outcomes of medical implants and tissue engineering therapies.

287 icine, inexpensive bioreactor technology and tissue engineering therapies.

288 Tissue engineering TMJ discs has emerged as an alternati

289 induced pluripotent stem cells (iPSCs) with tissue engineering to elucidate the pathophysiology unde

290 then discuss possible future applications of tissue engineering to virology, including current challe

291 he feasibility and applicability of this new tissue engineering tool in psychiatry.

292 nology appears to be promising for advancing tissue engineering toward functional tissue and organ fa

293 Tissue engineering using whole, intact cell sheets has s

294 A researcher trained in the principles of tissue engineering will be able to execute the protocol

295 an overview on current strategies of cardiac tissue engineering with a focus on different hydrogel me

296 ed to develop therapeutic strategies in bone tissue engineering with numerable clinical applications.

297 ly involved in drug delivery, biosensing and tissue engineering, with strong contributions to the who

298 In situ tissue engineering within a stroke cavity is gradually e

299 environment of the dental pulp, the triad of tissue engineering would require infection control, biom

300 d medical applications (e.g., drug delivery, tissue engineering, wound repair, etc.) through judiciou